Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer - Related Studies

Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

This study is ongoing, but not recruiting participants.

Study NCT00098631. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Head and Neck Cancer

2	Additional conditions recognized in this trial
		Carcinoma, Squamous Cell
		Head and Neck Neoplasms

3	More general conditions related to this trial
		Carcinoma
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Glandular and Epithelial
		Neoplasms, Squamous Cell

4	Interventions listed in this trial
		lapatinib ditosylate

5	Additional drug interventions recognized in this trial
		Lapatinib

6	More general drug interventions related to this trial
		Antineoplastic Agents
		Enzyme Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Protein Kinase Inhibitors
		Therapeutic Uses

7	Sponsors listed in this trial
		University of Chicago
		National Cancer Institute (NCI)